Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

Recent advances in virtual reality (VR) and augmented reality (AR) have introduced transformative approaches to molecular visualisation and interactive modelling. These immersive technologies allow ...